BioUtah joined the Biotech Across America State Symposium in Washington, D.C. on March 25 to discuss the strategic importance of strong state and local biotechnology ecosystems in bolstering national security and economic resilience. The symposium is a continuation of the National Security Commission on Emerging Biotechnology's Biotech Across America Roadshow, an initiative designed to highlight biotechnology across America, including companies, academic institutions, workforce development programs, and policy initiatives driving the industry's future.
The participation underscores Utah's significant role in the national biotech landscape. The state contributes substantially to the U.S. biotech industry, recognized as a startup hub, employing 180,000 people in the life sciences, and generating $22 billion in GDP. This economic footprint positions state-level ecosystems as critical components of national industrial and security strategy.
The symposium's focus stems from the work of the National Security Commission on Emerging Biotechnology (NSCEB), a legislative branch advisory entity. The Commission's purpose is to advance and secure biotechnology, biomanufacturing, and associated technologies for U.S. national security and to prepare the nation for the bioindustrial revolution. In April 2025, the Commission published a comprehensive report with recommendations for Congress and the federal government, available at https://biotech.senate.gov.
The event also involved organizations like the Engineering Biology Research Consortium (EBRC), a non-profit partnership advancing engineering biology for national and global needs, and the Federation of American Scientists (FAS). FAS, established in 1945, works to ensure scientific expertise informs policymaking on contemporary issues; more information is available at https://fas.org.
For Utah, representation at this national convening by BioUtah, the state's life sciences trade association, highlights the local industry's alignment with broader strategic goals. BioUtah's member companies span medical devices, biotechnology, biopharmaceuticals, diagnostics, and research, forming a key economic driver. More details about the association can be found at https://bioutah.org.
The implications of this discussion are multifaceted, linking economic vitality directly to national security. A robust, distributed biotech ecosystem across states like Utah reduces supply chain vulnerabilities, fosters innovation critical for medical and defense applications, and builds a skilled workforce. The Commission's roadshow and report signal a shift toward recognizing biotechnology not just as a sector for healthcare and commerce, but as a foundational element of economic and strategic resilience, with state-level initiatives being integral to a cohesive national strategy.
